M&A Readiness in 2026
For founders considering an exit in the next 3-5 years.
Strategic M&A will be the dominant exit path for revenue-mature healthcare companies over the next 3–5 years. The market has repriced around proof, not potential, and many teams are optimizing for the wrong signals.
What you'll learn:
What you'll learn:
- The diligence gates buyers test first (and where founders misread them).
- The gap between “fundable” and “acquirable.”
- A 12–18 month readiness path that creates leverage.
29 pages. Primary research (30+ conversations). Updated Jan 2026.
Access the full report.
Oops! Something went wrong while submitting the form.
Want insights to build exit optionality?
Access monthly intelligence from healthcare M&A, GTM, and buyer conversations.


